SciELO - Scientific Electronic Library Online

 
vol.19 número3Susceptibilidad antimicrobiana in vitro de cepas de Salmonella spp. en granjas de ponedoras comerciales del departamento de AntioquiaTorsión uterina causada por un hemangioma cavernoso en una hembra canina índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Revista Colombiana de Ciencias Pecuarias

versión impresa ISSN 0120-0690versión On-line ISSN 2256-2958

Resumen

ERRECALDE, Carlos A; PRIETO, Guillermo F; LUDERS, Carlos F  y  GARCIA OVANDO, Hugo. Pharmacokinetics and bioavailability of ceftiofur sodium in goats. Rev Colom Cienc Pecua [online]. 2006, vol.19, n.3, pp.306-311. ISSN 0120-0690.

Pharmacokinetic parameters of ceftiofur sodium were determined with a unique dose of 2.2 mg/kg either by the intravenous on the intramuscular routes, in a crossed design treatment in non pregnant adult female goats (n= 6). Variations in plasmatic concentrations over time were determined by the microbiological assay in Mueller-Hinton agar, with Providencia alcalifaciens as indicator. The limit of quantification was set in 0.039 mg/ml. The plasmatic concentrations of Ceftiofur were determined by the non compartimental pharmacokinetic model using sofware PK Solution 2.0. The parameters obtained when the intravenous route was used were: average elimination time (t1/2 b) = 1.63 ± 0.04 hours, total clearance (Cltot) = 3.3 ± 1.1 ml/kg/min, volume of distribution (Vdss) = 0.38 ± 0.19 L/Kg, area under the curve (ABC) = 716.5 ± 225.5 mg/min/ml. These values did not differ significantly from those obtained by the intramuscular test (P < 0.05) and are similar to those informed in other animal species for the same drug. When the intramuscular route was used , the maximum concentration (Cmáx) of 3.6 ± 0.5 mg/ml was obtained at a maximum time (tmáx) of 0.53 ± 0.31 min, and the bioavailability was high (97.6 ± 0.1%). The results indicate that the intramuscular application provides fast absorption and optimal bioavailability, generating plasmatic levels that exceed the MIC90 for sensitive respiratory pathogens for a period of 12 hours. Considering these results and a MIC (£0.06 mg/ml) for bacteria like Pasteurella haemolitica and multocida, the treatment of this type of infections in goats, requires 1.3 mg/Kg every 12 hours by intramuscular route, to obtain a predictive effectiveness (t> MIC) of 77.8%.

Palabras clave : ceftiofur; cephalosporins; goats; Pasteurella spp; pharmacokinetics.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons